百奥赛图将于12月10日在上交所科创板上市
Biocytogen Pharmaceuticals (Beijing)Biocytogen Pharmaceuticals (Beijing)(SH:688796) Bei Jing Shang Bao·2025-12-09 01:31

Core Viewpoint - BaiO Saite (688796) is set to be listed on the Shanghai Stock Exchange's Sci-Tech Innovation Board on December 10, with an issue price of 26.68 yuan per share [2]. Company Overview - BaiO Saite is an innovative drug preclinical CRO and biotechnology company, primarily engaged in providing antibody drug discovery and preclinical research services for innovative drug enterprises [2]. - The company's specific services include the sale of innovative model animals, preclinical pharmacology and efficacy evaluation services, and antibody development [2].